The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis

CONCLUSIONS: The use of colchicine reduces the risk of stroke in patients with a history of coronary artery disease, without a significant increase in gastrointestinal and myopathy/myalgia adverse effects.PMID:35538274 | DOI:10.1007/s11239-022-02659-9

Source: Atherosclerosis - May 10, 2022 Category: Cardiology Authors: Claire X Y Goh Ying Kiat Tan Choon Han Tan Aloysius S T Leow Jamie S Y Ho Natalie H W Tan Sherill Goh Andrew F W Ho Vijay K Sharma Bernard P L Chan Leonard L L Yeo Benjamin Y Q Tan Source Type: research